IGF1R signaling negatively impacts immune surveillance in breast cancer patients, as evidenced by IGF1R phosphorylation resulting in slight CD8+ CTL infiltration, significant infiltration of FOXP3+ regulatory T cells, immunosuppressive CD163+ macrophages, and poor prognosis [67]. This evidence concerns the gene FOXP3 and breast cancer.